Exosomal glycoprotein-130 (gp130) obtained from breast cancer cells was also observed to contribute to the progression of cancer through the activation of the IL-6/STAT3 pathway in macrophages thus leading to the alteration of normal macrophage phenotypes into pro-cancer phenotypes (Ham et al., 2018). This evidence concerns the gene IL6 and breast carcinoma.